Columbia Asset Management Moderna, Inc. Transaction History

Columbia Asset Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 26, 2022	SELL	$117.13 - $176.59 $259,442 - $391,146	-2,215 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $170,494 - $278,225	-755 Reduced 25.42%	2,215 $563,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $336,178 - $733,972	-1,515 Reduced 33.78%	2,970 $1.14 Million
Q2 2021 Aug 02, 2021	BUY	$129.91 - $234.98 $582,646 - $1.05 Million	4,485 New	4,485 $1.05 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

Stay updated on Columbia Asset Management with notifications on news.